Pre-Announced Drug Inspections To Continue At District Offices' Discretion
This article was originally published in The Tan Sheet
Executive Summary
FDA's pre-announced inspection program for drugs will continue at the discretion of district office management, a notice in the Jan. 4 Federal Register states.